LSTA: the balance sheet

MyFinsight

Balance Sheets	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Marketable securities	NaN	0	0	5,135
Cash and cash equivalents	13,060	15,956	18,998	16,835
Accounts receivable	NaN	0	502	501
Prepaid and other current assets	960	1,747	2,075	2,414
Total current assets	14,020	17,703	21,575	24,885
Property and equipment, net	16	18	22	48
Acquired license-intangible, net	NaN	0	139	157
Other assets	23	23	23	70
Total assets	14,059	17,744	21,759	25,160

Accounts payable	510	1,019	619	782
Accrued liabilities	2,805	2,052	3,949	3,531
Total current liabilities	3,315	3,071	4,568	4,313
Other long-term liabilities	72	72	72	72
Total liabilities	3,387	3,143	4,640	4,385
Common stock, 0.001 par value, authorized 500,000,000 shares issued 9,108,029 and 8,834,613 shares at march 31, 2026 and december 31, 2025, respectively and outstanding, 9,107,291 and 8,833,875 shares at march 31, 2026 and december 31, 2025, respectively	9	9	9	9
Additional paid-in capital	580,787	580,243	579,812	579,227
Treasury stock, at cost 738 shares at march 31, 2026 and december 31, 2025	708	708	708	708
Accumulated deficit	-569,141	-564,652	-561,698	-557,449
Accumulated other comprehensive loss	-21	-37	-42	-50
Total lisata therapeutics, inc. stockholders' equity	10,926	14,855	17,373	21,029
Non-controlling interests	-254	-254	-254	-254
Total equity	10,672	14,601	17,119	20,775
Total liabilities, non-controlling interests and stockholders' equity	14,059	17,744	21,759	25,160

Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.